Vice President Mike Pence

"It's only a matter of time, justice is coming," Jacob Chansley, the "QAnon Shaman," said in a handwritten note to Vice President Pence.

"I do not believe that such a course of action is in the best interest of our Nation or consistent with our Constitution," the vice president wrote on Tuesday evening.

Ratified in 1967, the 25th Amendment to the Constitution gives the vice president the ability to assume the powers of the presidency if he has the support of the executive Cabinet.

Lawmakers returned to the Capitol after hours of chaos in which protesters forced their way into the building and abruptly halted Congress' tally of Electoral College votes.

The extremists are calmly milling about the Capitol grounds, despite the D.C. curfew in effect. The relatively peaceful dispersal is in stark contrast with response to the summer's BLM protests.

The vice president, who chairs the White House coronavirus task force, is the most high-profile U.S. official so far to receive the vaccine.

Vice President Mike Pence’s announcement came as he was in Florida to attend a meeting of the National Space Council at Kennedy Space Center.

Pence visited the Centers For Disease Control and Prevention to highlight promising vaccine developments, but he received a grim assessment of the current state of the pandemic in the U.S.

The vice president made his first campaign appearance since he and President Trump lost their bid for reelection. He boosted Senate Republicans, while sidestepping the president's fraud claims.

The White House again faces the coronavirus in its ranks. But Vice President Pence, who has tested negative, plans to continue his breakneck campaign travel schedule.

Vice President Pence stressed a law and order message as protests over racism and policing continue. Republicans also worked to shore up support from suburban women and contrast visions of the future.

Vice President Mike Pence came to the University of Miami’s Miller School of Medicine on Monday, announcing the school's participation in Phase 3 trials...